Hangzhou Coco Healthcare Products Co.Ltd. Capital Reinvestment Ratio

Latest as of June 2025: 0.35x

Hangzhou Coco Healthcare Products Co.Ltd. capital reinvestment ratio. Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Capital Reinvestment Ratio of 0.35x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.21 Million) in capital expenditures (CN¥4.26 Million). Check 301009 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.35x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥12.21 Million
CNY

Capital Expenditures

CN¥4.26 Million
CNY

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)

Capital reinvestment ratio of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. This chart tracks Hangzhou Coco Healthcare Products Co.Ltd.'s Capital Reinvestment Ratio across 7 annual periods. Also explore net asset growth rate of Hangzhou Coco Healthcare Products Co.Ltd to track the company's year-over-year net asset growth rate.

Hangzhou Coco Healthcare Products Co.Ltd. Capital Reinvestment Ratio by Year (2017–2024)

Hangzhou Coco Healthcare Products Co.Ltd. capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Hangzhou Coco Healthcare Products Co.Ltd.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 1.44x CN¥52.44 Million CN¥75.35 Million ▲ +395.7%
2023 0.29x CN¥227.70 Million CN¥66.01 Million ▼ -93.9%
2021 4.76x CN¥50.53 Million CN¥240.45 Million ▲ +753.6%
2020 0.56x CN¥395.86 Million CN¥220.71 Million ▼ -1.1%
2019 0.56x CN¥223.33 Million CN¥125.86 Million ▼ -28.3%
2018 0.79x CN¥114.26 Million CN¥89.78 Million ▲ +11.4%
2017 0.71x CN¥109.74 Million CN¥77.41 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow